1. Home
  2. CVM
  3. CVM News

Latest Cel-Sci Corporation (CVM) News on October 23, 2024

FDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer Patients

Business Wire

20 hours ago

FDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer Patients

Associated Press Finance

2 months ago

Cel-Sci: Fiscal Q3 Earnings Snapshot

CVM: Confirmatory Study Clarity

Zacks Small Cap Research

5 months ago

CVM: Confirmatory Study Clarity

Associated Press Finance

5 months ago

Cel-Sci: Fiscal Q2 Earnings Snapshot

Zacks Small Cap Research

6 months ago

CVM: Parallel Engagement on Four Fronts

Associated Press Finance

8 months ago

Cel-Sci: Fiscal Q1 Earnings Snapshot

Zacks Small Cap Research

9 months ago

CVM: Fiscal Year 2023 in Review

Zacks Small Cap Research

a year ago

CVM: NICE To Have Your Support

Associated Press Finance

a year ago

Alta Equipment: Q3 Earnings Snapshot

Share on Social Networks: